To reduce unacceptably high death rates from snakebite envenomation, sub-Saharan Africa must adopt not only a new generation of multivalent biotech antivenoms, but also an infrastructure to deliver them.
- Roberto P Stock
- Achille Massougbodji
- Jean-Philippe Chippaux